Becton, Dickinson and Company beat Q4 收入估算, 保持了强劲的“Buy”股票评级。 Becton, Dickinson and Company beat Q4 earnings estimates, maintaining a strong "Buy" stock rating.

Becton、Dickinson和Company(BDX)看到一些机构投资者调整其股份,有些购买,有些出售股份。 Becton, Dickinson and Company (BDX) saw several institutional investors adjust their holdings, with some buying and others selling shares. 公司第四季度的每股收益为3.43美元, 超过分析师估计的0.43美元. The company reported fourth-quarter earnings of $3.43 per share, beating analyst estimates by $0.43. BDX以医疗用品和设备闻名,其市场上限为654.2亿美元,每季度支付每股1.04美元的股息,收益1.83%。 BDX, known for medical supplies and devices, has a market cap of $65.42 billion and pays a quarterly dividend of $1.04 per share, with a yield of 1.83%. 股票有一个一致的“Buy”评级,平均价格目标是278.29美元。 The stock has a consensus "Buy" rating and an average price target of $278.29.